Tiziana Life Sciences Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG889121031
USD
1.52
0.08 (5.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

108.23 k

Shareholding (Dec 2024)

FII

0.21%

Held by 10 FIIs

DII

99.58%

Held by 0 DIIs

Promoter

0.00%

How big is Tiziana Life Sciences Ltd.?

22-Jun-2025

As of Jun 18, Tiziana Life Sciences Ltd. has a market capitalization of 186.51 million, classifying it as a Micro Cap company. There is no valid financial data available for net sales or net profit for the latest four quarters.

Market Cap: As of Jun 18, Tiziana Life Sciences Ltd. has a market capitalization of 186.51 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for net sales or net profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: As of December 2024, the shareholder's funds are reported at 3.94 million, and total assets amount to 11.28 million.

Read More

What does Tiziana Life Sciences Ltd. do?

22-Jun-2025

Tiziana Life Sciences Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry with a market cap of USD 186.51 million. It is currently loss-making, with key metrics including a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -256.68%.

Overview: Tiziana Life Sciences Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: Market cap is USD 186.51 Million.<BR><BR>Key Metrics: P/E: NA (Loss Making), Dividend Yield: 0.00%, Debt Equity: -0.92, Return on Equity: -256.68%, Price to Book: 47.39.<BR><BR>Contact Details: No Company Details Available.

Read More

Is Tiziana Life Sciences Ltd. technically bullish or bearish?

25-Jun-2025

As of April 21, 2025, the trend has shifted to bullish, supported by positive MACD and moving averages, although a bearish monthly RSI slightly tempers the outlook.

As of 21 April 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish, primarily driven by the weekly and monthly MACD indicators, both of which are bullish. Additionally, the daily moving averages are bullish, supporting the overall positive trend. The Bollinger Bands indicate a mildly bullish stance on the weekly chart and bullish on the monthly chart. However, the monthly RSI shows a bearish signal, which slightly tempers the bullish outlook. Overall, the strength of the bullish trend is reinforced by the KST indicators being bullish on both weekly and monthly time frames.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 183 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.92

stock-summary
Return on Equity

-256.68%

stock-summary
Price to Book

46.52

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.48%
0%
-16.48%
6 Months
-5.0%
0%
-5.0%
1 Year
82.69%
0%
82.69%
2 Years
162.07%
0%
162.07%
3 Years
155.63%
0%
155.63%
4 Years
61.53%
0%
61.53%
5 Years
-29.0%
0%
-29.0%

Tiziana Life Sciences Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-16.92%
EBIT to Interest (avg)
-20.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0
Tax Ratio
29.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.36%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
41.07
EV to EBIT
-10.11
EV to EBITDA
-10.19
EV to Capital Employed
158.02
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1563.60%
ROE (Latest)
-256.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.22%)

Foreign Institutions

Held by 10 Foreign Institutions (0.21%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Tiziana Life Sciences Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 34.19% vs 10.34% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.70",
          "val2": "-29.10",
          "chgp": "39.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.40",
          "val2": "-23.40",
          "chgp": "34.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-17.70
-29.10
39.18%
Interest
0.00
0.20
-100.00%
Exceptional Items
-0.90
0.00
Consolidate Net Profit
-15.40
-23.40
34.19%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 34.19% vs 10.34% in Dec 2021

stock-summaryCompany CV
About Tiziana Life Sciences Ltd. stock-summary
stock-summary
Tiziana Life Sciences Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available